Plan better and budget smarter with expert insights and key analysis
Use the latest insights from our Vizient pharmacy experts to prepare your 2022 pharmacy budget. This comprehensive review includes market forecasts and drug price projections for the next 6 to 18 months, covering:
- Acute, non-acute, specialty and pediatrics
- Therapeutic class summaries
- Anticipated FDA approvals
- Market influences impacting drug spend
3.10%
Projected drug price inflation rate
for Jan. 1, 2022-Dec. 31, 2022
Get the Pharmacy Market Outlook
Cost reduction is a top priority. Take advantage of the Pharmacy Market Outlook to guide your pharmacy team.
Top drugs by total Vizient member spend
- Adalimumab continues to rank top of this list
- COVID-19 treatment drug, Remdesivir, enters the chart at number 3
- Oncology drugs continue to represent almost 25% of member spend
4.68%
Specialty pharmaceuticals
Projected drug price inflation rate*
Approval on treatments for rare diseases are at an accelerated pace.
Moving pharmacy forward
Connect with our pharmacy experts. We are here to support you.
*Based on Vizient member data April 2020-March 2021
Top categories include oncology, infectious diseases, hematological disorders and immunology.